INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 100 filers reported holding INFINITY PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 0.20 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $81,890 | +74.2% | 147,550 | +254.7% | 0.00% | – |
| Q1 2022 | $47,000 | -83.3% | 41,600 | -66.9% | 0.00% | – |
| Q4 2021 | $282,000 | -83.1% | 125,602 | -74.2% | 0.00% | – |
| Q3 2021 | $1,664,000 | +684.9% | 486,397 | +588.4% | 0.00% | – |
| Q2 2021 | $212,000 | +72.4% | 70,654 | +85.0% | 0.00% | – |
| Q1 2021 | $123,000 | +485.7% | 38,198 | +110.0% | 0.00% | – |
| Q4 2018 | $21,000 | -58.8% | 18,187 | -52.5% | 0.00% | – |
| Q2 2016 | $51,000 | -74.4% | 38,300 | +50.9% | 0.00% | -100.0% |
| Q4 2015 | $199,000 | -10.8% | 25,373 | +35.4% | 0.00% | 0.0% |
| Q1 2014 | $223,000 | – | 18,736 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 17,426,968 | $36,945,000 | 1.45% |
| Opaleye Management Inc. | 3,171,800 | $6,724,000 | 0.88% |
| EAM Investors, LLC | 421,103 | $893,000 | 0.15% |
| Bleichroeder LP | 250,000 | $530,000 | 0.10% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 755,593 | $1,602,000 | 0.04% |
| Callan Capital, LLC | 73,200 | $155,000 | 0.03% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 419,300 | $889,000 | 0.02% |
| Private Wealth Advisors, Inc. | 12,000 | $25,000 | 0.01% |
| Alpine Global Management, LLC | 24,575 | $52,000 | 0.01% |
| Evercore Wealth Management, LLC | 143,138 | $303,000 | 0.01% |